Historique
Bulletin de Périodique
Drug Testing and Analysis , Vol.11, n°8 - August 2019
Paru le :
01/08/2019
Année
2019
Page(s) :
1117-1276
Langue(s) :
Anglais
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Note de contenu :
SELECTION :
- In vitro metabolism of the novel synthetic opioid agonist cyclopropylfentanyl and subsequent confirmation in authentic human samples using liquid chromatography-high resolution mass spectrometry. Cutler C., Hudson S., p. 1134-1143.
- Syntheses and analytical characterizations of the research chemical 1-[1-(2-fluorophenyl)-2-phenylethyl]pyrrolidine (fluorolintane) and five of its isomers. Dybek M., Wallach J., Kavanagh P.V., Colestock T., Filemban N., Dowling G., et al., p. 1144-1161.
- Simultaneous quantification of ten key Kratom alkaloids in Mitragyna speciosa leaf extracts and commercial products by ultra-performance liquid chromatography-tandem mass spectrometry. Sharma A., Kamble S.H., Leon F., Chear N.J.-Y., King T.I., Berthold E.C., et al., p. 1162-1171.
- Variability in content and dissolution profiles of MDMA tablets collected in the UK between 2001 and 2018 - A potential risk to users? Couchman L., Frinculescu A., Sobreira C., Shine T., Ramsey J., Hecht M., et al., p. 1172-1182.
- Chemical profiling of the synthetic cannabinoid MDMB-CHMICA: Identification, assessment, and stability study of synthesis-related impurities in seized and synthesized samples. Münster-Müller S., Hansen S., Opatz T., Zimmermann R., Pütz M., p. 1192-1206.
- In vitro Phase I metabolism of indazole carboxamide synthetic cannabinoid MDMB-CHMINACA via human liver microsome incubation and high-resolution mass spectrometry. Presley B.C., Logan B.K., Jansen-Varnum S.A., p. 1264-1276.
- In vitro metabolism of the novel synthetic opioid agonist cyclopropylfentanyl and subsequent confirmation in authentic human samples using liquid chromatography-high resolution mass spectrometry. Cutler C., Hudson S., p. 1134-1143.
- Syntheses and analytical characterizations of the research chemical 1-[1-(2-fluorophenyl)-2-phenylethyl]pyrrolidine (fluorolintane) and five of its isomers. Dybek M., Wallach J., Kavanagh P.V., Colestock T., Filemban N., Dowling G., et al., p. 1144-1161.
- Simultaneous quantification of ten key Kratom alkaloids in Mitragyna speciosa leaf extracts and commercial products by ultra-performance liquid chromatography-tandem mass spectrometry. Sharma A., Kamble S.H., Leon F., Chear N.J.-Y., King T.I., Berthold E.C., et al., p. 1162-1171.
- Variability in content and dissolution profiles of MDMA tablets collected in the UK between 2001 and 2018 - A potential risk to users? Couchman L., Frinculescu A., Sobreira C., Shine T., Ramsey J., Hecht M., et al., p. 1172-1182.
- Chemical profiling of the synthetic cannabinoid MDMB-CHMICA: Identification, assessment, and stability study of synthesis-related impurities in seized and synthesized samples. Münster-Müller S., Hansen S., Opatz T., Zimmermann R., Pütz M., p. 1192-1206.
- In vitro Phase I metabolism of indazole carboxamide synthetic cannabinoid MDMB-CHMINACA via human liver microsome incubation and high-resolution mass spectrometry. Presley B.C., Logan B.K., Jansen-Varnum S.A., p. 1264-1276.
Cote :
Abonnement